Filing 2021 Q4 compared to 2021 Q3 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
Person Signing this Report on Behalf of Reporting Manager:
Name
Title
City, State
Date
Ansbert Gadicke
Member
Cambridge, Massachusetts
11 Feb 2022
The securities reported herein include securities previously included in the Form 13F filings of Burrage Capital Management LLC (File No. 028-20040), as Bioimpact Capital LLC acquired the assets of Burrage Capital Management LLC after June 30, 2021.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.